|
New Obesity Drug in Market
acomplia rimonabant zimulti Information .
|
Blog For Free!
Archives
Home
2006 October
2006 August
2006 July
2006 June
2006 May
My Links
acomplia
sanofi
tBlog
My Profile
Send tMail
My tFriends
My Images
Sponsored
Blog
|
| New Obesity Drug in Market |
| 07.03.06 (10:16 pm) [edit] |
A new international study has shown that 70% of Irish men and 54% of Irish women studied were considered overweight, while one quarter of Irish men and one--fifth of Irish women could be classified as clinically obese.
The IDEA study, a 63 country project including Ireland, coincides with the approval of a new anti-obesity drug, Acomplia , in the EU, which is due to be introduced in Ireland shortly. The Irish data in the study confirmed that there is a strong association between waist circumference and developing cardiovascular disease; men in the study with cardiovascular disease had a high body mass index and waist circumference. Consultant cardiologist at Tallaght Hospital Dr Vincent Maher said the study demonstrates the importance of measuring waist circumference as an indicator of cardiometabolic risk
Trials have shown that the drug can reduce body weight by 10%. Acomplia works by targeting body mechanisms that control appetite, metabolism, weight and energy use. Dr Maher said that before Acomplia there was no medication that addressed the multiple cardiometabolic risk factors that put patients at risk for cardiovascular disease and type 2 diabetes.
Acomplia works by decreasing overactivity of the endocannabinoid system, which helps regulate appetite.
Source:http://www.irishhealth.com/?l...
|
|
|
| |
|
|
